Rajesh Malik

CIK 1706853 · Chief Medical Officer · last filed 2024-09-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

47

Lifetime Open-Market Net

-$3.92M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
G1 Therapeutics, Inc. (GTHX) Delisted Chief Medical Officer 177,212 $7.15 $1.27M -$3.94M 42 2024-09-18
POINT Biopharma Global Inc. (PNT) Delisted Director 0 $12.50 $0 $24.6K 5 2023-12-27

Recent Filings · Page 5 of 5

47 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-05-16 G1 Therapeutics, Inc. (GTHX) Delisted Mixed -$159.1K EDGAR
2018-04-17 G1 Therapeutics, Inc. (GTHX) Delisted Mixed -$120.4K EDGAR
2018-03-16 G1 Therapeutics, Inc. (GTHX) Delisted Mixed -$140.8K EDGAR
2018-03-09 G1 Therapeutics, Inc. (GTHX) Delisted Exer (M) +4,200 $1.6K EDGAR
2018-02-16 G1 Therapeutics, Inc. (GTHX) Delisted Mixed -$74.3K EDGAR
2018-01-17 G1 Therapeutics, Inc. (GTHX) Delisted Mixed -$85.6K EDGAR
2018-01-04 G1 Therapeutics, Inc. (GTHX) Delisted Grant (A) $0 EDGAR
Showing 4147 of 47
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.